| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |